MOR · MorphoSys AG
Acquired Company
Novartis completed the acquisition of MorphoSys AG in May 2024 following a voluntary public takeover offer.
MorphoSys AG, discovers, develops and markets therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. The company is headquartered in Planegg, Germany.
SEMMELWEISSTRASSE 7, PLANEGG, GERMANY, 82152, Bayern, 82152, USA
BIOTECHNOLOGY
HEALTHCARE
Market Cap
2.856B
52 Wk Range
$0.00 - $0.00
Previous Close
$18.96
Open
$18.96
Volume
N/A
Day Range
$18.96 - $18.96
Enterprise Value
N/A
Cash
131.3M
Avg Qtr Burn
-64.43M
Insider Ownership
0.00%
Institutional Own.
7.44%
Qtr Updated
Mar 31st 2024